Who we are
Futura specialises in the development and global commercialisation of innovative consumer-focused sexual health products. Our lead projects are Eroxon®, (available commercially) and Eroxon® Intense and WSD4000 (both in-development). Our core strengths lie in our expertise in research and development, regulatory and business development in the sexual health market
Our Commercial Model
Futura’s business model is based on an ‘actively manage and optimise’ approach focused on a hybrid R&D and commercial approach which will provide greater flexibility, insight development and sharing and improved economic participation across markets.
Board of Directors
The Board has the overall responsibility to set the strategy for the Group and ensure that the Group delivers long term value to its shareholders.